RLY-2608
CAS: 2733573-94-7
Ref. TM-T81264
| 1mg | 502.00 € | ||
| 5mg | 997.00 € | ||
| 10mg | 1,612.00 € | ||
| 25mg | 2,404.00 € | ||
| 50mg | 3,243.00 € | ||
| 1mL*10mM (DMSO) | 1,331.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Product Information
Name:
RLY-2608
Synonyms:
- RLY2608
Description:
RLY-2608 is a variant PI3Kalpha inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
608.91
Formula:
C29H14ClF5N6O2
Purity:
98.7% - 98.96%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T81264 RLY-2608
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
